Cargando…

Mobility and associations with levels of cerebrospinal fluid amyloid β and tau in a memory clinic cohort

BACKGROUND: Mobility impairments, in terms of gait and balance, are common in persons with dementia. To explore this relationship further, we examined the associations between mobility and cerebrospinal fluid (CSF) core biomarkers for Alzheimer’s disease (AD). METHODS: In this cross-sectional study,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tangen, Gro Gujord, Sverdrup, Karen, Taraldsen, Kristin, Persson, Karin, Engedal, Knut, Bekkhus-Wetterberg, Peter, Knapskog, Anne-Brita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939466/ https://www.ncbi.nlm.nih.gov/pubmed/36820757 http://dx.doi.org/10.3389/fnagi.2023.1101306

Ejemplares similares

Editorial: Mobility in older adults with cognitive impairment
por: Bogen, Bård, et al.
Publicado: (2023)

Diagnostic accuracy of brain age prediction in a memory clinic population and comparison with clinically available volumetric measures
por: Persson, Karin, et al.
Publicado: (2023)

Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients
por: Knapskog, Anne-Brita, et al.
Publicado: (2017)

The Effects of Tau, Amyloid, and White Matter Lesions on Mobility, Dual Tasking, and Balance in Older People
por: Nilsson, Maria H, et al.
Publicado: (2020)

Cerebrospinal fluid sTREM2 in Alzheimer’s disease: comparisons between clinical presentation and AT classification
por: Knapskog, Anne-Brita, et al.
Publicado: (2020)

Mobility and cognition at admission to the nursing home – a cross-sectional study
por: Sverdrup, Karen, et al.
Publicado: (2018)

Malnutrition Is Associated With Impaired Functional Status in Older People Receiving Home Care Nursing Service
por: Leão, Luana Lemos, et al.
Publicado: (2021)

A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease
por: Edwin, Trine Holt, et al.
Publicado: (2020)

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection
por: Gisslén, Magnus, et al.
Publicado: (2009)

Amyloid-β PET—Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic
por: Müller, Ebba Gløersen, et al.
Publicado: (2019)

Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies
por: Canaslan, Sezgi, et al.
Publicado: (2021)

Associations between Cognition and Hand Function in Older People Diagnosed with Mild Cognitive Impairment or Dementia
por: Hesseberg, Karin, et al.
Publicado: (2020)

Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer’s Disease in a Memory Clinic Cohort
por: Aksnes, Mari, et al.
Publicado: (2020)

Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles
por: Delaby, Constance, et al.
Publicado: (2022)

Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer’s Disease
por: Aksnes, Mari, et al.
Publicado: (2021)

Exploring life-space in the nursing home. An observational longitudinal study
por: Sverdrup, Karen, et al.
Publicado: (2021)

Preoperative cerebrospinal fluid β-Amyloid/Tau ratio and postoperative delirium
por: Xie, Zhongcong, et al.
Publicado: (2014)

Editorial: The heart-brain connection in emotions, cognition, and dementia
por: Hestad, Knut A., et al.
Publicado: (2022)

Cerebrospinal fluid catecholamines in Alzheimer’s disease patients with and without biological disease
por: Henjum, Kristi, et al.
Publicado: (2022)

Association between vascular comorbidity and progression of Alzheimer’s disease: a two-year observational study in Norwegian memory clinics
por: Eldholm, Rannveig Sakshaug, et al.
Publicado: (2018)

Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway
por: Strand, Bjørn Heine, et al.
Publicado: (2018)

Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease
por: Aksnes, Mari, et al.
Publicado: (2021)

Investigation of coenzyme Q10 status, serum amyloid-β, and tau protein in patients with dementia
por: Chang, Po-Sheng, et al.
Publicado: (2022)

Activated gliosis, accumulation of amyloid β, and hyperphosphorylation of tau in aging canines with and without cognitive decline
por: Hines, Amelia D., et al.
Publicado: (2023)

Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid
por: Voyle, Nicola, et al.
Publicado: (2016)

Early increase of cerebrospinal fluid 14-3-3ζ protein in the alzheimer's disease continuum
por: Lu, Yuanyuan
Publicado: (2022)

Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with de novo Parkinson’s disease
por: Sheng, Ze-Hu, et al.
Publicado: (2022)

Syntaxins 6 and 8 facilitate tau into secretory pathways
por: Lee, Wei Siang, et al.
Publicado: (2021)

Age-dependent accumulation of tau aggregation in Caenorhabditis elegans
por: Aquino Nunez, Wendy, et al.
Publicado: (2022)

Pathogenic tau decreases nuclear tension in cultured neurons
por: Sohn, Claira, et al.
Publicado: (2023)

Interrater and test-retest reliability and validity of the Norwegian version of the BESTest and mini-BESTest in people with increased risk of falling
por: Hamre, Charlotta, et al.
Publicado: (2017)

Multiomics Analysis of Structural Magnetic Resonance Imaging of the Brain and Cerebrospinal Fluid Metabolomics in Cognitively Normal and Impaired Adults
por: Eldridge, Ronald C., et al.
Publicado: (2022)

Membrane interaction and disulphide-bridge formation in the unconventional secretion of Tau
por: Hellén, Marianna, et al.
Publicado: (2021)

Shapeshifting tau: from intrinsically disordered to paired-helical filaments
por: Mengham, Kurtis, et al.
Publicado: (2022)

The ANeED study – ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial
por: Chwiszczuk, Luiza Jadwiga, et al.
Publicado: (2023)

Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson’s Disease
por: Mo, Mingshu, et al.
Publicado: (2021)

MRI-assessed atrophy subtypes in Alzheimer’s disease and the cognitive reserve hypothesis
por: Persson, Karin, et al.
Publicado: (2017)

Amyloid-β in Alzheimer’s disease – front and centre after all?
por: Weglinski, Caroline, et al.
Publicado: (2023)

Increased mortality risk for adults aged 25–44 years with long-term disability: A prospective cohort study with a 35-year follow-up of 30,080 individuals from 1984–2019 in the population-based HUNT study
por: Langballe, Ellen Melbye, et al.
Publicado: (2022)

Association between cerebrospinal fluid clusterin and biomarkers of Alzheimer’s disease pathology in mild cognitive impairment: a longitudinal cohort study
por: Wang, Hao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_887lfvdstv2jf0ab3qdd7rsjum